Humus Capital Partners
Humus Capital Partners LLC is a private equity firm based in Buenos Aires, Argentina, focusing on middle market and emerging growth investments. Established in 2009, the firm specializes in industry consolidation, buyouts, turnarounds, and growth capital investments, primarily within sectors such as animal protein, frozen foods, hospitality and leisure, education, healthcare, and retail, particularly in Latin America. Humus Capital Partners aims to invest approximately $20 million in its portfolio companies, typically seeking a majority stake and taking a seat on the board of directors. The firm plans to exit its investments through initial public offerings or sales to strategic buyers while avoiding investments in the land and agriculture sectors.
Private Equity Round in 2018
Biosidus S.A. is a biotechnology company based in Buenos Aires, Argentina, specializing in the development, manufacturing, and supply of biosimilars. Established in 1983, it has become the largest manufacturer and distributor of biosimilar pharmaceuticals in the region, with a product portfolio that includes therapeutic proteins such as Epoetin, Filgrastim, Somatropin, and Lenograstim, among others. The company operates two manufacturing plants: one focused on research and development and the production of pharmaceutical active ingredients, while the other handles aseptic filling, lyophilization, and packing. Biosidus also invests in innovative technologies, including transgenic animals and gene therapy, aimed at treating vascular diseases and various chronic conditions like cancer and osteoporosis. With a strong pipeline of products in various stages of development and operations across Asia, Africa, Eastern Europe, and Latin America, Biosidus is positioned as a key provider of high-quality biopharmaceuticals on a global scale.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.